Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NT-MDT is a scientific instrumentation company focused on scanning probe microscopy, atomic force microscopy, and related nanoscale analytical systems. The company develops and sells research-grade microscopes, probes, accessories, and integrated platforms such as AFM-Raman and nanomechanics systems for academic, industrial, and applied research users. Its products are used across materials science, semiconductor research, nanotechnology, and some life-science and biomaterials applications, including biological AFM workflows. Despite limited exposure to therapeutics or clinical development, NT-MDT appears to be an active commercial company with international sales and service operations, including activities branded as NT-MDT Spectrum Instruments and NT-MDT America. For biotech analysts, it is best categorized as a tools/instrumentation vendor serving parts of the life-science research market rather than a drug developer or healthcare services company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NT-MDT.